January, 2005:
- Fosamax patent ruling another blow for Merck
- Greenfield Online acquires Rapidata.net
- British Medical Journal retracts Prozac report
- Cialis set for Super Bowl return
- AstraZeneca expects earnings rise despite Crestor, Exanta, Iressa questions
- MS&L opens Quebec office and names SVP
- Two Industry Veterans Launch JYT Health
- Pharma companies increase prices on popular drugs
- Johnson & Johnson sees global pharmaceutical sales jump
- Mindspan adds Jim King as VP, business development
- Final Medicare Rx benefit rules unveiled
- ISN and NPG partner to create new journal
- FDA approves 31 NMEs in 2004, 10 more than in 2003
- Mobic’s blockbuster potential follows COX-2 bad news
- Novartis to air eye Rx ad during first half of Super Bowl
- MediaVest transfer prompted by assignment concentration
- Ortho-McNeil seeks NDA for premature ejaculation drug
- Pfizer purchases Angiosyn, deal to close in first quarter
- Former Aventis executives now in new Novo Nordisk posts
- Chandler Chicco acquires Korea communications firm
- Bristol-Myers Squibb, Ventiv ink multi-year service deal
- Ogilvy and Healthworld merge to form new agency
- Journal study raises questions about Plavix
- Prounis launches new agency
- Competitive market should keep drug prices down, HHS nominee says
- CommonHealth launches new agency
- Drug Store News, NACDS to host Rx marketing event for seniors
- FDA to again decide on OTC switch for Plan B contraceptive
- Schering-Plough makes changes in its R&D operations
- FDA panel rejects OTC request for Mevacor
- J&J's Christine Poon accepts additional roles
- FDA panel considers nonprescription sale of Mevacor
- Palio makes several promotions
- FDA issues warning over Celebrex, Bextra ads
- Chandler Chicco Agency acquires Ignition Strategic Communications
- Stonefly adds five to its staff
- Big pharma launches new discount card
- Prescription drug spending slows
- AstraZeneca’s Crestor linked to a death
- Publicis Selling Solutions launches first CSO sales force
- Par taps MacPhee as new SVP, branded marketing and sales
- Legal challenge to Lipitor worries Wall Street
- Novartis taps Euro for Elidel, Lamisil med ed
- Bayer buys rights to market Levitra abroad
- New form of Taxol approved.
- Sudler & Hennessey acquires Current Medical Directions
- Consumer health exposition to focus on family caregivers
- Redi-Mail acquires PPS Medical Marketing Group
- People, Product and Agency News from the Jan. 7th MM&M News Brief
- Torre Lazur McCann names Ouimette as president
- Schering-Plough names Omnicom, Publicis to handle Rx ads
- AZ cuts 500 contract sales jobs
- Drug companies urged to improve R&D strategies
- Andrx abandons brand-name drug business
- USP issues final Medicare drug benefit plan
- Seasonale warned by FDA for ads
- McCarthy promoted at Lanmark Group
- Setback for Pfizer drug Lyrica
Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.
MMM Articles
- Novartis psoriasis drug approval could upend market
- Sandoz gets ready to make the biosimilar case with oncologists
- Guidemark Health jumpstarts rebrand, brings on big-agency grad
- MM&M's 5 minutes with: Mark Rothera, chief commercial officer, PTC Therapeutics
- Nurse practitioner workforce has just about doubled
